Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site

Melissa CableDiscover Vision Centers, Independence, MO, USAPurpose: The purpose of this study was to investigate the clinical outcomes of bromfenac ophthalmic solution 0.09% once daily (QD) and nepafenac 0.1% ophthalmic suspension three times daily following cataract extraction with posterior chambe...

Full description

Saved in:
Bibliographic Details
Main Author: Cable M
Format: article
Language:EN
Published: Dove Medical Press 2012
Subjects:
Online Access:https://doaj.org/article/5c54c28b907f468cb892a58b05516290
Tags: Add Tag
No Tags, Be the first to tag this record!